225 related articles for article (PubMed ID: 36921601)
1. Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer.
Du M; Gu D; Xin J; Peters U; Song M; Cai G; Li S; Ben S; Meng Y; Chu H; Chen L; Wang Q; Zhu L; Fu Z; Zhang Z; Wang M
Cell Rep Med; 2023 Mar; 4(3):100974. PubMed ID: 36921601
[TBL] [Abstract][Full Text] [Related]
2. Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer.
Yang J; Zhao Y; Yuan R; Wang Y; Wang S; Chang Z; Zhao W
Eur J Med Res; 2023 Nov; 28(1):533. PubMed ID: 37986009
[TBL] [Abstract][Full Text] [Related]
3. A Transcriptome and Methylome Study Comparing Tissues of Early and Late Onset Colorectal Carcinoma.
Kibriya MG; Raza M; Quinn A; Kamal M; Ahsan H; Jasmine F
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430738
[TBL] [Abstract][Full Text] [Related]
4. [Multi-omics research progress in early-onset colorectal cancer].
Chen SL; Xin JY; Du ML; Wang ML
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):447-451. PubMed ID: 38778683
[TBL] [Abstract][Full Text] [Related]
5. Sporadic early-onset colorectal cancer is a specific sub-type of cancer: a morphological, molecular and genetics study.
Kirzin S; Marisa L; Guimbaud R; De Reynies A; Legrain M; Laurent-Puig P; Cordelier P; Pradère B; Bonnet D; Meggetto F; Portier G; Brousset P; Selves J
PLoS One; 2014; 9(8):e103159. PubMed ID: 25083765
[TBL] [Abstract][Full Text] [Related]
6. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location.
Chen Y; Chen Z; Huang J; Hu J; He X; Lan P; He X
Int J Clin Oncol; 2022 Apr; 27(4):749-755. PubMed ID: 35079898
[TBL] [Abstract][Full Text] [Related]
8. Distinct plasma molecular profiles between early-onset and late-onset colorectal cancer patients revealed by metabolic and lipidomic analyses.
Zhang S; Xu R; Hu M; Choueiry F; Jin N; Li J; Mo X; Zhu J
J Pharm Biomed Anal; 2024 Apr; 241():115978. PubMed ID: 38237540
[TBL] [Abstract][Full Text] [Related]
9. Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset colorectal cancer: A retrospective cohort study on 34067 patients managed from 2000 to 2021 in a Chinese tertiary center.
Gao XH; Li J; Liu LJ; Zheng NX; Zheng K; Mei Z; Bai CG; Zhang W
Int J Surg; 2022 Aug; 104():106780. PubMed ID: 35850466
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.
He X; Liu X; Zuo F; Shi H; Jing J
Semin Cancer Biol; 2023 Jan; 88():187-200. PubMed ID: 36596352
[TBL] [Abstract][Full Text] [Related]
11. Lemur tyrosine kinase-3 is a significant prognostic marker for patients with colorectal cancer.
Shi H; Li Q; Ji M; Wu J; Li Z; Zheng X; Xu B; Chen L; Li X; Lu C; Tan Y; Wu C; Jiang J
Int J Clin Exp Pathol; 2014; 7(3):1101-7. PubMed ID: 24695631
[TBL] [Abstract][Full Text] [Related]
12. Multi-omics analysis to identify driving factors in colorectal cancer.
Xu X; Gong C; Wang Y; Hu Y; Liu H; Fang Z
Epigenomics; 2020 Sep; 12(18):1633-1650. PubMed ID: 32573269
[No Abstract] [Full Text] [Related]
13. Lemur tyrosine kinase-3 (LMTK3) induces chemoresistance to cetuximab in colorectal cancer via the ERK/MAPK pathway.
Wang C; Yang M; Gu X; Gu Y
Bioengineered; 2021 Dec; 12(1):6594-6605. PubMed ID: 34516351
[TBL] [Abstract][Full Text] [Related]
14. Identification of differentially expressed genes and splicing events in early-onset colorectal cancer.
Marx OM; Mankarious MM; Koltun WA; Yochum GS
Front Oncol; 2024; 14():1365762. PubMed ID: 38680862
[TBL] [Abstract][Full Text] [Related]
15. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic landscape of early age onset of colorectal cancer identifies novel genes and pathways in Indian CRC patients.
Singh MP; Rai S; Singh NK; Srivastava S
Sci Rep; 2021 Jun; 11(1):11765. PubMed ID: 34083590
[TBL] [Abstract][Full Text] [Related]
17. An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy.
Sibilio P; Belardinilli F; Licursi V; Paci P; Giannini G
Biol Direct; 2022 May; 17(1):10. PubMed ID: 35534873
[TBL] [Abstract][Full Text] [Related]
18. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing.
Xie T; Cho YB; Wang K; Huang D; Hong HK; Choi YL; Ko YH; Nam DH; Jin J; Yang H; Fernandez J; Deng S; Rejto PA; Lee WY; Mao M
Genomics; 2014 Oct; 104(4):234-41. PubMed ID: 25066378
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
20. NOMO-1 gene is deleted in early-onset colorectal cancer.
Perea J; García JL; Pérez J; Rueda D; Arriba M; Rodríguez Y; Urioste M; González-Sarmiento R
Oncotarget; 2017 Apr; 8(15):24429-24436. PubMed ID: 28416736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
